Ghazaleh Tabatabai Selected Research

Proteins (Proteins, Gene)

3/2024	Functionally-instructed modifiers of response to ATR inhibition in experimental glioma.
6/2022	Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
5/2022	AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.
4/2021	FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma.
1/2020	A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.
1/2019	Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma.
9/2015	Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition.
10/2014	Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.
2/2013	Integrin control of the transforming growth factor-β pathway in glioblastoma.
1/2013	Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ghazaleh Tabatabai Research Topics

Disease

73	Neoplasms (Cancer) 06/2024 - 09/2005
57	Glioma (Gliomas) 03/2024 - 09/2005
55	Glioblastoma (Glioblastoma Multiforme) 07/2024 - 09/2006
16	Meningioma (Meningiomas) 05/2024 - 01/2019
11	Brain Neoplasms (Brain Tumor) 12/2023 - 10/2006
6	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 07/2012
5	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2013
4	Neurofibromatosis 2 (Neurofibromatosis Type II) 08/2022 - 11/2019
4	Oligodendroglioma 05/2022 - 12/2014
4	Melanoma (Melanoma, Malignant) 02/2020 - 02/2013
4	Hypoxia (Hypoxemia) 09/2015 - 09/2006
3	Necrosis 03/2024 - 02/2022
3	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 11/2019
3	Intellectual Disability (Idiocy) 09/2019 - 01/2016
2	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2024 - 01/2020
2	Edema (Dropsy) 11/2023 - 01/2022
2	Lymphoma (Lymphomas) 01/2023 - 01/2023
2	Disease Progression 05/2022 - 03/2013
2	Neurilemmoma (Schwannoma) 01/2021 - 11/2019
2	alpha-Thalassemia 09/2019 - 01/2017
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 11/2018
1	Multiple Sclerosis 12/2023
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2023
1	Genomic Instability 01/2023

Drug/Important Bio-Agent (IBA)

18	Temozolomide (Temodar)FDA LinkGeneric 09/2023 - 09/2006
15	Biomarkers (Surrogate Marker)IBA 06/2024 - 09/2010
15	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2022 - 10/2013
13	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2003
9	Bevacizumab (Avastin)FDA Link 07/2024 - 12/2009
9	MethyltransferasesIBA 07/2024 - 09/2010
8	Messenger RNA (mRNA)IBA 11/2023 - 10/2006
8	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 09/2010
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 02/2007
7	IntegrinsIBA 01/2019 - 12/2009
6	CytokinesIBA 01/2023 - 12/2009
6	Peptides (Polypeptides)IBA 05/2022 - 01/2011
5	Lomustine (CCNU)FDA Link 09/2023 - 12/2014
5	Phosphotransferases (Kinase)IBA 01/2023 - 09/2015
5	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2006
5	Alkylating AgentsIBA 12/2019 - 09/2010
5	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2016 - 10/2008
5	CilengitideIBA 03/2014 - 12/2009
4	ParaffinIBA 07/2023 - 10/2006
4	somatostatin receptor 2IBA 08/2022 - 01/2018
4	AntigensIBA 01/2019 - 01/2015
3	Protein Subunit VaccinesIBA 10/2023 - 01/2021
3	Ganciclovir (Cytovene)FDA LinkGeneric 01/2023 - 01/2022
3	Thymidine KinaseIBA 01/2023 - 01/2022
3	somatostatin receptor type 1IBA 08/2022 - 01/2018
3	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2022 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2014
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2019 - 11/2018
3	EnzymesIBA 03/2013 - 08/2010
3	Neutralizing AntibodiesIBA 02/2013 - 09/2005
3	CaspasesIBA 02/2011 - 09/2008
3	Transforming Growth Factor beta (TGF-beta)IBA 10/2008 - 09/2005
2	Small Interfering RNA (siRNA)IBA 03/2024 - 08/2010
2	Lysine (L-Lysine)FDA Link 10/2023 - 01/2021
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2023 - 01/2018
2	tyrosine receptor (receptor, tyrosine)IBA 01/2023 - 06/2022
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022 - 02/2013
2	larotrectinibIBA 06/2022 - 02/2021
2	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 12/2019
2	alpha-hydroxyglutarateIBA 01/2022 - 10/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2021 - 11/2019
2	VaccinesIBA 01/2021 - 01/2019
2	Histones (Histone)IBA 01/2021 - 01/2016
2	NVP-BKM120IBA 01/2020 - 12/2016
2	regorafenibIBA 12/2019 - 11/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 09/2019 - 01/2018
2	O-(6)-methylguanineIBA 09/2019 - 01/2017
2	InterferonsIBA 03/2019 - 09/2012
2	LigandsIBA 01/2019 - 09/2006
2	ProteomeIBA 01/2019 - 11/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 12/2009
2	NF-kappa B (NF-kB)IBA 01/2018 - 10/2008
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 12/2015
2	Conditioned Culture MediaIBA 12/2016 - 02/2013
2	Antineoplastic Agents (Antineoplastics)IBA 12/2016 - 02/2013
2	cyclic arginine-glycine-aspartic acid peptideIBA 02/2013 - 01/2011
2	Angiogenesis InhibitorsIBA 02/2013 - 12/2009
1	boldenone undecylenate (Equipoise)IBA 05/2024
1	sulfur tetrafluorideIBA 11/2023
1	Methionine (L-Methionine)FDA Link 10/2023
1	AcidsIBA 06/2023
1	NucleotidesIBA 01/2023
1	Growth Factor ReceptorsIBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023

Therapy/Procedure

41	Therapeutics 06/2024 - 09/2005
25	Radiotherapy 07/2024 - 02/2007
14	Drug Therapy (Chemotherapy) 01/2023 - 09/2010
7	Immunotherapy 05/2022 - 08/2010
6	Chemoradiotherapy 10/2019 - 09/2010
4	Adjuvant Radiotherapy 07/2023 - 11/2019
3	Precision Medicine 06/2024 - 09/2010
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2021 - 12/2019
2	Intravenous Injections 04/2012 - 06/2010
1	Stem Cell Transplantation 01/2023
1	Aftercare (After-Treatment) 01/2023